000 | 01785 a2200529 4500 | ||
---|---|---|---|
005 | 20250513030531.0 | ||
264 | 0 | _c19960117 | |
008 | 199601s 0 0 eng d | ||
022 | _a0006-2952 | ||
024 | 7 |
_a10.1016/0006-2952(95)02021-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aParsons, M E | |
245 | 0 | 0 |
_aProperties of the reversible, K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties. _h[electronic resource] |
260 |
_bBiochemical pharmacology _cNov 1995 |
||
300 |
_a1551-6 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aAminoquinolines _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntacids _xpharmacology |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastric Acid _xmetabolism |
650 | 0 | 4 |
_aGastric Fistula _xphysiopathology |
650 | 0 | 4 |
_aGastric Juice _xdrug effects |
650 | 0 | 4 |
_aGastric Mucosa _xdrug effects |
650 | 0 | 4 |
_aHistamine Antagonists _xpharmacology |
650 | 0 | 4 | _aHydrogen-Ion Concentration |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOmeprazole _xpharmacology |
650 | 0 | 4 |
_aPotassium _xmetabolism |
650 | 0 | 4 | _aProton Pump Inhibitors |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aSecretory Rate _xdrug effects |
650 | 0 | 4 |
_aStomach _xenzymology |
700 | 1 | _aRushant, B | |
700 | 1 | _aRasmussen, T C | |
700 | 1 | _aLeach, C | |
700 | 1 | _aIfe, R J | |
700 | 1 | _aPostius, S | |
700 | 1 | _aPope, A J | |
773 | 0 |
_tBiochemical pharmacology _gvol. 50 _gno. 10 _gp. 1551-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0006-2952(95)02021-7 _zAvailable from publisher's website |
999 |
_c7503223 _d7503223 |